Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safetyPALOMBI, Leonardo; PIRILLO, Maria F; PICHINI, Simona et al.Antiviral therapy (London). 2012, Vol 17, Num 8, pp 1511-1519, issn 1359-6535, 9 p.Article

Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics studyCICCACCI, Cinzia; DI FUSCO, Davide; MARAZZI, Maria C et al.European journal of clinical pharmacology. 2013, Vol 69, Num 11, pp 1909-1916, issn 0031-6970, 8 p.Article

HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from MozambiqueBORGIANI, Paola; DI FUSCO, Davide; ERBA, Fulvio et al.European journal of clinical pharmacology. 2014, Vol 70, Num 3, pp 275-278, issn 0031-6970, 4 p.Article

Immunologic Response to Highly Active Antiretroviral Therapy and Mortality Reduction in a Cohort of Human Immunodeficiency Virus-Positive Persons in MozambiquePALOMBI, Leonardo; DORRUCCI, Maria; ZIMBA, Ines et al.The American journal of tropical medicine and hygiene. 2010, Vol 83, Num 5, pp 1128-1132, issn 0002-9637, 5 p.Article

Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomesMARAZZI, Maria C; PALOMBI, Leonardo; NARCISO, Pasquale et al.AIDS (London). 2011, Vol 25, Num 13, pp 1611-1618, issn 0269-9370, 8 p.Article

Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of lifeMARAZZI, Maria C; LIOTTA, Giuseppe; NIELSEN-SAINES, Karin et al.AIDS (London). 2010, Vol 24, Num 18, pp 2819-2826, issn 0269-9370, 8 p.Article